annual ROE:
185.16%+509.36%(+157.11%)Summary
- As of today (September 16, 2025), XERS annual return on equity is 185.16%, with the most recent change of +509.36% (+157.11%) on December 31, 2024.
- During the last 3 years, XERS annual ROE has risen by +375.44% (+197.31%).
- XERS annual ROE is now at all-time high.
Performance
XERS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
113.91%-46.57%(-29.02%)Summary
- As of today (September 16, 2025), XERS quarterly return on equity is 113.91%, with the most recent change of -46.57% (-29.02%) on June 30, 2025.
- Over the past year, XERS quarterly ROE has dropped by -645.33% (-85.00%).
- XERS quarterly ROE is now -85.00% below its all-time high of 759.24%, reached on June 30, 2024.
Performance
XERS quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XERS ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +157.1% | -85.0% |
3 y3 years | +197.3% | +147.2% |
5 y5 years | +166.2% | +135.2% |
XERS ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +157.1% | -85.0% | +111.2% |
5 y | 5-year | at high | +149.0% | -85.0% | +111.2% |
alltime | all time | at high | +149.0% | -85.0% | +111.2% |
XERS ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | 113.91%(-29.0%) |
Mar 2025 | - | 160.48%(-36.8%) |
Dec 2024 | 185.16%(-157.1%) | 253.86%(-36.1%) |
Sep 2024 | - | 397.13%(-47.7%) |
Jun 2024 | - | 759.24%(-174.5%) |
Mar 2024 | - | -1019.20%(+181.5%) |
Dec 2023 | -324.20%(+140.5%) | -362.12%(+73.2%) |
Sep 2023 | - | -209.08%(+27.5%) |
Jun 2023 | - | -163.95%(+26.8%) |
Mar 2023 | - | -129.34%(-0.0%) |
Dec 2022 | -134.83%(-29.1%) | -129.37%(-37.9%) |
Sep 2022 | - | -208.23%(-13.8%) |
Jun 2022 | - | -241.47%(-11.3%) |
Mar 2022 | - | -272.24%(-15.3%) |
Dec 2021 | -190.28% | -321.60%(-24.6%) |
Sep 2021 | - | -426.67%(+39.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | -306.33%(+9.7%) |
Mar 2021 | - | -279.18%(-30.2%) |
Dec 2020 | -378.20%(+35.3%) | -399.80%(-3.2%) |
Sep 2020 | - | -413.17%(+27.8%) |
Jun 2020 | - | -323.33%(+33.4%) |
Mar 2020 | - | -242.44%(+21.8%) |
Dec 2019 | -279.56%(+168.6%) | -199.09%(+39.7%) |
Sep 2019 | - | -142.55%(+38.8%) |
Jun 2019 | - | -102.70%(+17.4%) |
Mar 2019 | - | -87.48%(+13.8%) |
Dec 2018 | -104.08%(+39.2%) | -76.85%(+28.8%) |
Sep 2018 | - | -59.65%(-59.6%) |
Jun 2018 | - | -147.83%(-195.0%) |
Mar 2018 | - | 155.60%(+639.2%) |
Dec 2017 | -74.79%(+75.3%) | 21.05% |
Dec 2016 | -42.66% | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual return on equity?
- What is the all time high annual ROE for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual ROE year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly ROE year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual return on equity?
The current annual ROE of XERS is 185.16%
What is the all time high annual ROE for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual return on equity is 185.16%
What is Xeris Biopharma Holdings, Inc. annual ROE year-on-year change?
Over the past year, XERS annual return on equity has changed by +509.36% (+157.11%)
What is Xeris Biopharma Holdings, Inc. quarterly return on equity?
The current quarterly ROE of XERS is 113.91%
What is the all time high quarterly ROE for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly return on equity is 759.24%
What is Xeris Biopharma Holdings, Inc. quarterly ROE year-on-year change?
Over the past year, XERS quarterly return on equity has changed by -645.33% (-85.00%)